McNabb S J, Graves D C, Kosanke S D, Moyer M J, Ivey M H
Department of Microbiology and Immunology, University of Oklahoma, Health Sciences Center, Oklahoma City 73190.
J Clin Microbiol. 1988 Sep;26(9):1763-71. doi: 10.1128/jcm.26.9.1763-1771.1988.
We developed a modified double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) that detected relatively low concentrations of known Pneumocystis carinii antigen added to buffer or rat sera. Artificial immunization-derived polyclonal rabbit anti-P. carinii antibody was used on the solid phase to capture the antigen. Infection-derived (after P. carinii pneumonia) polyclonal rat anti-P. carinii antibody or a mixture of five murine monoclonal antibodies was used as the antigen detector antibody. Rabbit anti-rat immunoglobulin G antibody or goat anti-mouse immunoglobulin G antibody conjugated to alkaline phosphatase was used as the final antibody. After standardization and optimization of the various reactants in this ELISA system, approximately 53 ng of known P. carinii antigen per ml suspended in phosphate-buffered saline-Tween 20 buffer or 210 ng of antigen per ml suspended in normal rat serum diluted 1:4 could be detected. In addition, an indirect ELISA for P. carinii antibody measurement was developed, using as the antigen a soluble supernatant from a sonicated preparation of Percoll-purified whole cysts and trophozoites to coat the solid phase. Limited studies with sera from a small number of caesarian-obtained, barrier-sustained rats from Charles River Breeding Laboratories, Inc., and the National Institutes of Health and sera from normal and heavily infected rats indicated that the caesarian-obtained, barrier-sustained rats had negligible levels of antibody. The normal and heavily infected rats had variable antibody titers. A significantly high level of P. carinii antigenemia was detected in only 2 (11%) of 18 heavily infected rats. Extensive studies of the P. carinii pneumonia rat model with the ELISA did not reveal significant serum P. carinii antigenemia during the acute stage of infection. However, soluble P. carinii antigen was detected by the ELISA and Western blot assays in the supernatant of lavage fluid after centrifugation to sediment intact organisms. As expected, P. carinii antigens were detected by these assays in the lavage pellet recovered after centrifugation. In conclusion, the antigen assay used in this study detected P. carinii antigen in lung lavage but failed to detect P. carinii antigen in rat serum during the acute phase of infection.
我们开发了一种改良的双抗体夹心酶联免疫吸附测定法(ELISA),该方法可检测添加到缓冲液或大鼠血清中的已知卡氏肺孢子虫抗原的相对低浓度。人工免疫衍生的兔抗卡氏肺孢子虫多克隆抗体用于固相捕获抗原。感染衍生的(卡氏肺孢子虫肺炎后)大鼠抗卡氏肺孢子虫多克隆抗体或五种鼠单克隆抗体的混合物用作抗原检测抗体。与碱性磷酸酶偶联的兔抗大鼠免疫球蛋白G抗体或山羊抗小鼠免疫球蛋白G抗体用作最终抗体。在对该ELISA系统中的各种反应物进行标准化和优化后,每毫升悬浮于磷酸盐缓冲盐水 - 吐温20缓冲液中的已知卡氏肺孢子虫抗原约53 ng或每毫升悬浮于1:4稀释的正常大鼠血清中的210 ng抗原均可被检测到。此外,还开发了一种用于测量卡氏肺孢子虫抗体的间接ELISA,使用来自Percoll纯化的完整囊肿和滋养体超声破碎制剂的可溶性上清液作为抗原包被固相相固相。对来自Charles River Breeding Laboratories, Inc.和美国国立卫生研究院的少量剖腹产获得的、屏障维持的大鼠血清以及正常和重度感染大鼠血清进行的有限研究表明,剖腹产获得的、屏障维持的大鼠抗体水平可忽略不计。正常和重度感染大鼠的抗体滴度各不相同。在18只重度感染大鼠中,仅2只(11%)检测到显著高水平的卡氏肺孢子虫抗原血症。用ELISA对卡氏肺孢子虫肺炎大鼠模型进行的广泛研究未发现感染急性期血清中有显著的卡氏肺孢子虫抗原血症。然而,在离心沉淀完整生物体后,通过ELISA和蛋白质印迹分析在灌洗液上清液中检测到可溶性卡氏肺孢子虫抗原。正如预期的那样,这些检测方法在离心后回收的灌洗沉淀物中检测到了卡氏肺孢子虫抗原。总之,本研究中使用的抗原检测方法在肺灌洗中检测到了卡氏肺孢子虫抗原,但在感染急性期未能在大鼠血清中检测到卡氏肺孢子虫抗原。